Recombinant Sheep SDHD is a genetically engineered form of the succinate dehydrogenase complex subunit D, produced to study its structural and functional roles in mitochondrial energy metabolism. This transmembrane protein anchors the succinate dehydrogenase (SDH) complex (Complex II) to the inner mitochondrial membrane, facilitating electron transfer from succinate to ubiquinone during the citric acid cycle and oxidative phosphorylation .
Key functional attributes include:
Ubiquinone Binding: SDHD interacts with ubiquinone via hydrogen bonds (e.g., Tyr83) to stabilize its orientation during electron transport .
Disease Linkages: Defective SDHD is associated with mitochondrial disorders and tumors such as paragangliomas due to dysregulated hypoxia signaling .
Recombinant Sheep SDHD is synthesized using in vitro expression systems, primarily Escherichia coli, to ensure high yield and purity . Key variants include full-length and partial constructs, with optional tags (e.g., His, Fc) for purification or detection .
| Product Code | Expression System | Tag | Application |
|---|---|---|---|
| CSB-CF682918SH | E. coli | Non-tagged | Structural studies |
| CSB-EP682918SH1-B | Mammalian cells | Biotinylated | Protein interaction assays |
Studies using hybrid SDH complexes (e.g., yeast and bacterial paralogs) reveal critical insights into recombinant SDHD's catalytic efficiency :
| Strain | Cytochrome c Reductase Activity (% Wild Type) | Decylubiquinone Reductase Activity (% Wild Type) |
|---|---|---|
| Wild Type (SDH3/SDH4) | 100% | 100% |
| SHH3 Hybrid | 68% | 57% |
| SHH4 Hybrid | 30% | 23% |
Hybrid enzymes containing recombinant SDHD analogs exhibit reduced but measurable activity, highlighting its role in electron transport . Thermal denaturation assays further show that recombinant SDHD-containing complexes are less stable than wild-type enzymes .
Recombinant Sheep SDHD is utilized in:
Mitochondrial Disorders: Models for SDH deficiency syndromes, such as Leigh syndrome, to study metabolic flux disruptions .
Cancer Research: Investigating pseudohypoxic drive in tumors linked to SDHD mutations .
Structural Biology: Mapping ubiquinone-binding sites and heme interactions in Complex II .
The OVT73 transgenic sheep model (expressing mutant HTT) includes SDHD-related metabolomic and proteomic datasets, enabling systems-level analysis of mitochondrial dysfunction in Huntington’s disease . Public databases (e.g., HD Sheep Database) provide interactive tools for correlating SDHD expression with neurological or metabolic phenotypes .
Membrane-anchoring subunit of succinate dehydrogenase (SDH), a component of mitochondrial complex II in the electron transport chain. It facilitates electron transfer from succinate to ubiquinone (coenzyme Q).
KEGG: oas:780442
UniGene: Oar.12987
SDHD (Succinate dehydrogenase [ubiquinone] cytochrome b small subunit) is one of four proteins that constitute the succinate dehydrogenase (SDH) complex in the mitochondrial inner membrane. This complex plays a crucial role in both the tricarboxylic acid cycle and the electron transport chain. The specific function of SDHD is to anchor the complex to the mitochondrial membrane and facilitate electron transfer from succinate to ubiquinone in the respiratory chain .
Methodologically, researchers can verify SDHD function through:
Enzyme activity assays measuring succinate oxidation rates
Complex II-driven oxygen consumption measurements in isolated mitochondria
Membrane potential assessments before and after succinate addition
Sheep SDHD shares significant homology with SDHD from other mammalian species, particularly in the conserved regions essential for heme binding and interaction with other SDH subunits. While the complete sequence comparison data for sheep SDHD is limited, functional domains typically show >85% conservation across mammals.
For researchers conducting comparative studies, it is recommended to:
Perform multiple sequence alignments using CLUSTAL Omega or similar tools
Generate phylogenetic trees to visualize evolutionary relationships
Conduct structural modeling using Swiss-Model or AlphaFold2 to predict sheep-specific structural features
Expression of functional recombinant sheep SDHD presents unique challenges due to its hydrophobic nature and requirement for proper mitochondrial targeting.
Recommended Expression Systems:
| Expression System | Advantages | Limitations | Yield (mg/L) |
|---|---|---|---|
| E. coli BL21(DE3) with pET vectors | High yield, cost-effective | Lacks post-translational modifications | 1-3 |
| Insect cells (Sf9) with baculovirus | Better folding, some PTMs | Moderate cost, longer production time | 2-5 |
| Mammalian cells (CHO, HEK293) | Native-like folding and PTMs | Higher cost, lower yield | 0.5-2 |
Methodological considerations:
Include a cleavable N-terminal tag (His6 or GST) to facilitate purification
Co-express with chaperones (GroEL/ES) when using bacterial systems
For functional studies, consider co-expression with other SDH subunits
Optimize induction conditions (temperature: 16-18°C, IPTG: 0.1-0.5 mM) for bacterial expression
Multiple detection approaches can be employed depending on the research question:
Western Blotting: A 1:1,000 dilution of anti-SDHD antibody effectively detects SDHD in various cell lysates. The expected molecular weight for sheep SDHD is approximately 17 kDa .
Immunohistochemistry: For tissue sections, use a 1:100 dilution of anti-SDHD antibody with antigen retrieval in citrate buffer (pH 6.0). This approach allows visualization of SDHD distribution within tissues .
Flow Cytometry: For cellular studies, approximately 0.1 μg antibody per one million cells can detect SDHD in permeabilized cells .
Mass Spectrometry: For unbiased detection, targeted LC-MS/MS approaches using multiple reaction monitoring (MRM) can quantify sheep SDHD peptides with high sensitivity.
CRISPR/Cas9 gene editing offers powerful approaches for investigating SDHD function through targeted modifications:
Methodological workflow:
Design stage:
Select target sequences in sheep SDHD gene using tools like CHOPCHOP or CRISPOR
Design sgRNAs with minimal off-target effects
Prepare homology-directed repair (HDR) templates for precise modifications
Delivery methods for sheep embryos:
Microinjection of CRISPR components into zygotes
Electroporation of sheep embryos
Verification approaches:
Based on similar gene editing studies in sheep, precise base substitution efficiency can reach ~31.6% when combining CRISPR/Cas9 with ssODN templates and SCR7 (a ligase IV inhibitor) . This approach allows creating defined mutations to study SDHD function without disrupting other sheep traits.
Integrating SDHD data within multi-omic frameworks presents unique challenges:
Data normalization: Different data types (transcriptomic, proteomic, metabolomic) require specialized normalization approaches to enable cross-platform comparison.
Statistical considerations:
For small sample sizes (n=6 per group is common in sheep studies), use permutation tests and bootstrapping methods to assess significance
Apply differential correlation statistics to identify changes in regulatory networks
Calculate Z-statistics to determine significance of correlation structure changes between conditions
Computational integration strategies:
Visualization approaches:
Integration of metabolic flux data with SDHD expression levels
Network analysis showing SDHD interactions within mitochondrial pathways
Heat maps of correlated variables across different tissues
SDHD dysfunction has significant metabolic implications due to its central role in energy production:
Primary effects:
Decreased succinate oxidation
Reduced electron flow through complex II
Accumulation of succinate as a metabolic intermediate
Secondary consequences:
Altered reactive oxygen species (ROS) production
Metabolic reprogramming toward glycolytic pathways
Potential pseudohypoxic signaling due to succinate accumulation
Metabolomic profiling of TCA cycle intermediates
Measurements of mitochondrial membrane potential
Respiratory capacity assessments in isolated mitochondria
Seahorse XF analysis of oxygen consumption rates
Several testing approaches can be implemented for identifying SDHD variants in sheep:
PCR-RFLP analysis:
Amplify SDHD exonic regions
Digest with appropriate restriction enzymes to identify known mutations
Analyze fragment patterns on agarose gels
Sanger sequencing:
Direct sequencing of SDHD coding regions
Best for confirming suspected mutations in individual animals
Next-Generation Sequencing approaches:
Targeted sequencing panels including SDHD and related genes
Whole exome sequencing for comprehensive variant detection
Analysis pipeline should include sheep-specific reference sequences
High-resolution melting analysis:
When implementing genetic testing programs, consider:
Appropriate sampling strategies for flock representation
Including positive and negative controls
Following up screening tests with confirmatory methods
Developing a database of identified variants for reference
Co-immunoprecipitation (Co-IP) experiments are valuable for studying SDHD protein interactions:
Methodological workflow:
Sample preparation:
Fresh mitochondrial isolation from sheep tissues (preferably heart, liver, or skeletal muscle)
Gentle solubilization with digitonin (0.5-1%) or DDM (0.5-1%) to preserve protein complexes
Pre-clearing with protein A/G beads to reduce non-specific binding
Immunoprecipitation strategy:
Controls and validation:
Include IgG negative control
Perform reciprocal Co-IPs with antibodies against known interacting partners
Validate with alternative approaches (e.g., proximity ligation assay)
Detection methods:
Western blotting for known interactors
Mass spectrometry for unbiased identification of interacting proteins
Multi-omic integration provides comprehensive insights into SDHD regulation:
Transcriptomic analysis:
RNA-seq to identify transcriptional regulation of SDHD and related genes
Analysis of alternative splicing events affecting SDHD expression
Integration with ChIP-seq data to identify transcription factors regulating SDHD
Proteomic approaches:
Quantitative proteomics to measure SDHD abundance
Post-translational modification analysis by phosphoproteomics and other PTM enrichment strategies
Protein turnover studies using SILAC or similar labeling approaches
Metabolomic integration:
Targeted analysis of TCA cycle intermediates
Correlation of succinate/fumarate ratios with SDHD expression levels
Flux analysis using 13C-labeled substrates
Data integration framework:
Example integration workflow:
Generate datasets from the same animals at a single timepoint
Normalize each dataset independently
Integrate using unique sample identifiers across datasets
Perform correlation analysis between datasets
Visualize relationships using network analysis or heat maps
Antibody validation is critical for reliable SDHD research:
Specificity issues:
Problem: Cross-reactivity with other proteins
Solution: Test antibody against SDHD knockout/knockdown samples
Solution: Perform peptide competition assays
Sensitivity limitations:
Reproducibility challenges:
Problem: Batch-to-batch variation
Solution: Standardize positive controls across experiments
Solution: Test multiple antibody lots where possible
Application-specific validation:
Recommended validation workflow:
Test antibody against recombinant sheep SDHD protein
Verify specificity in sheep tissue lysates using appropriate controls
Document optimal conditions for each application
Maintain detailed protocols for reproducibility
Recombinant SDHD often presents solubility and stability challenges:
Common issues and solutions:
| Problem | Potential Causes | Solutions |
|---|---|---|
| Inclusion body formation | Overexpression, improper folding | Lower induction temperature (16-18°C), reduce IPTG concentration, co-express with chaperones |
| Poor solubility | Hydrophobic membrane domains | Use mild detergents (DDM, CHAPS, Triton X-100), test detergent screens |
| Protein degradation | Protease activity, instability | Add protease inhibitors, maintain samples at 4°C, avoid freeze-thaw cycles |
| Loss of cofactors | Heme dissociation during purification | Include stabilizing agents in buffers, consider gentle purification methods |
Stability optimization approaches:
Buffer optimization: Test different pH values (6.5-8.0) and salt concentrations (100-300 mM NaCl)
Additive screening: Evaluate glycerol (5-20%), reducing agents (DTT, β-ME), and stabilizing agents
Storage conditions: Compare different temperatures (-80°C, -20°C, 4°C) and effects of lyophilization